ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TRLV vs RGC // EV/EBITDA & P/E VALUATION

Trulieve Cannabis Corp. Subordinate Voting Shares (NYSE) VS. Regencell Bioscience Holdings Limited (NASDAQ) • 15-METRIC TALLY: TRLV 3 — RGC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRLV VS. RGC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TRLV RGC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 60.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 12.80% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 9.9x — — TIE /valuation <GO>
Free Cash Flow Yield 11.20% -0.10% +11.30 TRLV /fcf-yield <GO>
Operating Margin 12.10% — — TIE /operating-margins <GO>
Net Profit Margin -9.90% — — TIE /net-margins <GO>
Revenue Growth (YoY) -0.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.12 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 2/9 +4.00 TRLV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.3 42.8 +0.49 TRLV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.04B $3.40B -$1.36B RGC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TRLV REV RGC REV TRLV GROSS % RGC GROSS % TRLV FCF RGC FCF
FY 2025 $1.18B $0 60.2% — $228.6M -$3.3M
FY 2024 $1.19B $0 60.3% — $148.9M -$4.0M
FY 2023 $1.13B $0 — — $201.8M -$5.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRLV // BETA —
RGC // BETA —